DrugPatentWatch Database Preview

LAZANDA Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Lazanda patents expire, and what generic alternatives are available?

Lazanda is a drug marketed by Elefsee Pharms Intl and is included in one NDA. There are six patents protecting this drug.

This drug has eighty-two patent family members in thirty-two countries.

The generic ingredient in LAZANDA is fentanyl citrate. There are thirty-one drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.

Summary for LAZANDA

International Patents:	82
US Patents:	6
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	26
Clinical Trials:	5
Patent Applications:	4,661
Formulation / Manufacturing:	see details
DailyMed Link:	LAZANDA at DailyMed

Pharmacology for LAZANDA

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

US Patents and Regulatory Information for LAZANDA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-001	Jun 30, 2011		RX	Yes	No
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-003	Dec 21, 2015		RX	Yes	No			Y
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-001	Jun 30, 2011		RX	Yes	No			Y
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-002	Jun 30, 2011		RX	Yes	Yes			Y

  Purchase this report

or, see our see our flat-rate plans

Expired US Patents for LAZANDA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-002	Jun 30, 2011
Elefsee Pharms Intl	LAZANDA	fentanyl citrate	SPRAY, METERED;NASAL	022569-001	Jun 30, 2011

  Purchase this report

or, see our see our flat-rate plans

International Patents for LAZANDA

Country	Document Number	Estimated Expiration
Slovenia	1635783
South Korea	101012148
Norway	335127
Croatia	P20161168

Supplementary Protection Certificates for LAZANDA

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
00521	Netherlands		PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006
2006000022	Germany		PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126
00522	Netherlands		PRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006
00523	Netherlands		PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006